CIOMS FORM

SUSPECT ADVERSE REACTION REPORT

I. REACTION INFORMATION

1. PATIENT INITIALS

1a. COUNTRY

2. DATE OF BIRTH

2a. AGE

3. SEX

4-6 REACTION ONSET

8-12 CHECK ALL

(first, last)

 

Day

Month

Year

Years

 

Day

Month

Year

APPROPRIATE
TO ADVERSE
REACTION

7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data) Serious Unexpected

¨ PATIENT DIED

¨ INVOLVED OR
PROLONGED
INPATIENT
HOSPITALISATION

¨ INVOLVED
PERSISTENT OR
SIGNIFICANT
DISABILITY OR
INCAPACITY

¨ LIFE
THREATENING

II. SUSPECT DRUG(S) INFORMATION

14. SUSPECT DRUG(S) (include generic name)

20. DID REACTION
ABATE AFTER
STOPPING DRUG?

¨ YES ¨ NO ¨ NA

15. DAILY DOSE(S)

16. ROUTE(S) OF ADMINISTRATION

21. DID REACTION
REAPPEAR
AFTER REINTRO-

17. INDICATION(S) FOR USE

DUCTION?

¨ YES ¨ NO ¨ NA

18. THERAPY DATES (from/to)

19. THERAPY DURATION

III. CONCOMITANT DRUG(S) AND HISTORY

22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)
Drug (substance) Begindate - Enddate

 

23. OTHER RELEVANT HISTORY (e.g. diagnoses, allergies, pregnancy with last menstrual period, etc.)

 

IV. MANUFACTURER INFORMATION

24a. NAME AND ADDRESS OF MANUFACTURER

COMMENTS

ORIGINAL REPORT NO.

24b. MFR CONTROL NO.

Reporting source:

24c. DATE RECEIVED
BY MANUFACTURER

24d. REPORT SOURCE
¨ STUDY ¨ LITERATURE
¨ HEALTH PROFESSIONAL

DATE OF THIS REPORT

25a. REPORT TYPE
¨ INITIAL ¨ FOLLOW-UP